Advertisement
Loading...

Cerus Corporation

CERSNASDAQ
Healthcare
Medical - Devices
$2.34
$-0.17(-6.77%)
U.S. Market opens in 37h 17m

Cerus Corporation Fundamental Analysis

Cerus Corporation (CERS) shows moderate financial fundamentals with a PE ratio of -48.69, profit margin of -4.29%, and ROE of -15.36%. The company generates $0.2B in annual revenue with strong year-over-year growth of 14.35%.

Key Strengths

Cash Position17.70%
PEG Ratio-0.77
Current Ratio1.63

Areas of Concern

ROE-15.36%
Operating Margin-7.94%
We analyze CERS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 9.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
9.5/100

We analyze CERS's fundamental strength across five key dimensions:

Efficiency Score

Weak

CERS struggles to generate sufficient returns from assets.

ROA > 10%
-4.28%

Valuation Score

Excellent

CERS trades at attractive valuation levels.

PE < 25
-48.69
PEG Ratio < 2
-0.77

Growth Score

Excellent

CERS delivers strong and consistent growth momentum.

Revenue Growth > 5%
14.35%
EPS Growth > 10%
25.45%

Financial Health Score

Moderate

CERS shows balanced financial health with some risks.

Debt/Equity < 1
1.44
Current Ratio > 1
1.63

Profitability Score

Weak

CERS struggles to sustain strong margins.

ROE > 15%
-1536.18%
Net Margin ≥ 15%
-4.29%
Positive Free Cash Flow
No

Key Financial Metrics

Is CERS Expensive or Cheap?

P/E Ratio

CERS trades at -48.69 times earnings. This suggests potential undervaluation.

-48.69

PEG Ratio

When adjusting for growth, CERS's PEG of -0.77 indicates potential undervaluation.

-0.77

Price to Book

The market values Cerus Corporation at 6.88 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.88

EV/EBITDA

Enterprise value stands at -28.37 times EBITDA. This is generally considered low.

-28.37

How Well Does CERS Make Money?

Net Profit Margin

For every $100 in sales, Cerus Corporation keeps $-4.29 as profit after all expenses.

-4.29%

Operating Margin

Core operations generate -7.94 in profit for every $100 in revenue, before interest and taxes.

-7.94%

ROE

Management delivers $-15.36 in profit for every $100 of shareholder equity.

-15.36%

ROA

Cerus Corporation generates $-4.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.28%

Following the Money - Real Cash Generation

Operating Cash Flow

Cerus Corporation generates limited operating cash flow of $2.72M, signaling weaker underlying cash strength.

$2.72M

Free Cash Flow

Cerus Corporation generates weak or negative free cash flow of $-1.26M, restricting financial flexibility.

$-1.26M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

CERS converts -0.26% of its market value into free cash.

-0.26%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-48.69

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.77

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.15

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.15

vs 25 benchmark

How CERS Stacks Against Its Sector Peers

MetricCERS ValueSector AveragePerformance
P/E Ratio-48.6928.62 Better (Cheaper)
ROE-15.36%783.00% Weak
Net Margin-4.29%-48181.00% (disorted) Weak
Debt/Equity1.440.39 Weak (High Leverage)
Current Ratio1.634.12 Neutral
ROA-4.28%-21914.00% (disorted) Weak

CERS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cerus Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

92.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

77.54%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

123.37%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ